[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-arcutis-biotherapeutics-nasdaq3301924ee0-2fdb-7afd-b3a4-51ea4c2daa4a":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":10,"showTags":10,"source":11,"reactions":12,"selfReactions":13,"logo":14,"sourceId":15,"sourceUserId":16,"asset":17,"tagsCategories":18,"totalComments":19,"lang":20,"unique_views_count":21,"enrichStatus":17,"triageKind":16,"triageImportance":16,"expandEligible":16,"summarizeEligible":16,"eventEligible":16,"eventType":16,"eventAction":16},"arcutis-biotherapeutics-nasdaq3301924ee0-2fdb-7afd-b3a4-51ea4c2daa4a","1727898726000","Arcutis Biotherapeutics (NASDAQ:ARQT) Stock Price Up 6.5%","Arcutis Biotherapeutics (NASDAQ:ARQT) Shares Up 6.5%","https://www.marketbeat.com/instant-alerts/nasdaq-arqt-percent-advance-2024-10-02/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Other\"]","0","EN","4"]